Siddhartha Dutta
Biographic Data
| ID | 10001058 |
|---|---|
| NAME | Siddhartha Dutta |
| GIVEN NAMES | Siddhartha |
| FAMILY NAME | Dutta |
| SIGNATURE | DUTTA S |
| AFFILIATIONS | All India Institute of Medical Sciences Jodhpur |
| ORCID | 0000-0001-6525-5950 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Forecasting the emergence, development, and impact of industry 4.0 technologies for defence sector in terms of sustainability and innovation
Currently, industry 4.0 technologies have revolutionised every field for digital transformation, real-time monitoring, and innovative infrastructure. Real-time insights across war fighting and real-time decision support to individual and realistic training scenarios for soldiers are all positive outcomes of assimilating Industry 4.0 into Defence. In this study, we have presented a detailed discussion on the significance of Industry 4.0 technologi…
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050
BACKGROUND: Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we produced location-specific, age-specific, and sex-specific estimates of diabetes prevalence and burden from 1990 to 2021, the proportion of type 1 and type 2 diabetes…
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. Long-acting insulin analogues were developed to reduce hypoglycaemia and improve adherence. Their considerably higher costs though have impacted their funding and use. Biosimilars …
Rapid Assessment of Price Instability and Paucity of Medicines and Protection for Covid-19 Across Asia
Background: Countries have introduced a variety of measures to prevent and treat COVID-19 with medicines and personal protective equipment (PPE), with some countries adopting preventative strategies earlier than others. However, there has been considerable controversy surrounding some treatments. This includes hydroxychloroquine where the initial hype and misinformation lead to shortages, price rises and suicides. Price rises and shortages have a…
No prominent works on this page.
Rapid Assessment of Price Instability and Paucity of Medicines and Protection for Covid-19 Across Asia
Background: Countries have introduced a variety of measures to prevent and treat COVID-19 with medicines and personal protective equipment (PPE), with some countries adopting preventative strategies earlier than others. However, there has been considerable controversy surrounding some treatments. This includes hydroxychloroquine where the initial hype and misinformation lead to shortages, price rises and suicides. Price rises and shortages have a…
The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
Background: Diabetes mellitus rates continue to rise, which coupled with increasing costs of associated complications has appreciably increased global expenditure in recent years. The risk of complications are enhanced by poor glycaemic control including hypoglycaemia. Long-acting insulin analogues were developed to reduce hypoglycaemia and improve adherence. Their considerably higher costs though have impacted their funding and use. Biosimilars …
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050
BACKGROUND: Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), we produced location-specific, age-specific, and sex-specific estimates of diabetes prevalence and burden from 1990 to 2021, the proportion of type 1 and type 2 diabetes…
Forecasting the emergence, development, and impact of industry 4.0 technologies for defence sector in terms of sustainability and innovation
Currently, industry 4.0 technologies have revolutionised every field for digital transformation, real-time monitoring, and innovative infrastructure. Real-time insights across war fighting and real-time decision support to individual and realistic training scenarios for soldiers are all positive outcomes of assimilating Industry 4.0 into Defence. In this study, we have presented a detailed discussion on the significance of Industry 4.0 technologi…
Business (3 works) · Environmental health (3 works) · Medicine (3 works) · Pharmaceutical Economics and Policy (2 works) · Political science (2 works) · Public health (2 works) · Antibiotic Use and Resistance (1 works) · Big Data and Business Intelligence (1 works) · Biology (1 works) · Biosimilar (1 works)